Graduate of Royal College of Surgeons in Ireland, Dr Rezal, completed Basic Surgical Training in Midwestern Regional Hospital, Limerick, Ireland. He is the first Malaysian awarded, the Irish Scholarship for Research Fellow in University of Milwaukee and presented his research on Neuroblastoma in the Annual Congress Surgical meeting in New Orleans in 2003. He completed the MRCS(Ire) in 2007 and further obtained a Diploma in Laparoscopic Surgery in Strasbourg, France in 2006. He pursued in Master of Surgery in University Malaya, National Colorectal Surgery Fellowship and in 2022, completed Subspecialty Training in Advanced Colorectal and Peritoneal Malignancy with special interest in Cytoreductive Surgery (CRS) with Hyperthemic Intraoperative Chemotherapy (HIPEC) and Pressurized IntraPeritioneal Aerosol Chemotherapy (PIPAC) in HUKM and National Cancer Centre in Singapore and Singapore General Hospital respectively. He sits as a member of the European Society of Surgical Oncology, Academy of Medicine Malaysia,Malaysian Society of Colorectal Surgeons and International Society for the study of Pleura and Peritoneum (ISSPP).

Dr. Ramasamy earned her PhD in Clinical Medicine Research Programme (specialisation: human embryonic stem cell research) from the Department of Surgery and Cancer, Hammersmith Hospital, Imperial College London, UK. She is heading the Stem Cell Biology Laboratory, Department of Molecular Medicine, a research group focussing on Regenerative Medicine, Stem Cell Technology and Cancer Stem Cell research. Her passion for developing and driving industrial partnerships has steered to a number of successful MOAs and collaborative endeavours through her management of, including, Cell & Molecular Biology Laboratory (CMBL), Central Research Laboratories (CRL) Faculty of Medicine (FOM). During her leadership role as head of the Internationalisation Unit, FOM (IUFOM), many collaborative and networking activities were embarked at the national and international arena paving the path towards excellence in the research and academic portfolio of the faculty and university. She also has been serving the Industrial and Community Engagement (UMICE) portfolio as the chief liaison officer for FOM. Dr. Ramasamy has been actively engaged in stem cell research for more than a decade now and recently embarked on cancer stem cell research, the research field that she has so much passion. Her research group has set their focus to strive for innovative and creative cutting edge research in developing effective stem cell therapy and target cancer stem cells by developing scientific programs of exceptional merit in collaboration with multiple institutions and industries at national and international levels. She has been leading and involved in many research programmes/grants at national and international levels. She has been invited to present the research findings in many national and international meetings as keynote and invited speaker. Her passion for bringing the impact of regenerative research in Malaysia to a great height is very much evident through her leadership role as the President of Tissue Engineering and Regenerative Medicine Society of Malaysia (TESMA) [2015-2019], Advisory Committee for Tissue Engineering and Regenerative Medicine International Society (TERMIS) World Congress 2021 and many other national and international meetings. As the founding advisor of the Malaysian Society for Extracellular Vesicles (MySEV) and Co-founder of the Innovation Forum-Kuala Lumpur (IFKL) Chapter, she is aspired to build the network with international institutions and societies. Collaborative Intelligence is what Dr. Ramasamy firmly believed in.

Professor Dr. See Mee-Hoong Professor Dr. See Mee-Hoong is an esteemed senior lecturer at the University of Malaya and a dedicated Consultant Oncoplastic Breast Surgeon at the University Malaya Medical Center (UMMC). Graduating with her undergraduate medical degree from UPM in 2003, she continued her academic excellence by earning her Master's Degree in Surgery (General Surgery) from the University of Malaya in May 2011 and obtained her fellowship in Breast Oncoplastic training from 2012 to 2015 in Universiti Malaya and Mahidol University, Thailand. Currently, she is nationally registered as a Breast Oncoplastic Surgeon. Her commitment to medical education and clinical practice led her to join the University Malaya Medical Faculty in 2012, where she specialized as a clinical lecturer focusing on Breast Oncoplastic Surgery. Dr. See further honed her skills as an honorary fellow at Siriraj Hospital, Mahidol University, Bangkok, Thailand in 2013, and later completed advanced training in minimally invasive techniques and Cryoablation at Kameda Medical Centre under Dr. Eisuke Fukuma in 2016. In 2022, Dr. See underwent robotic breast surgery training at Chang Hua Christian Medical Centre, Taichung, Taiwan. She has since pioneered minimally invasive breast surgeries at UMMC, offering patients the benefits of early recovery, smaller scars, better aesthetic outcomes, and comparable oncological results. A pioneer in Malaysia, she introduced 2D and 3D endoscopic nipple-sparing mastectomy (NSM) as early as 2019 and pioneer the FIRST MALAYSIA Robotic NSM with immediate implant reconstruction in 2025 . She has also been elected as a council member of Breast Surgical International in 2024, marking significant milestones in her leadership and expertise. Dr. See serves as the clinical head of the Breast Surgery Unit at UMMC (currently known as the Breast and Endocrine Unit), where she leads a team committed to providing high-quality care to patients. Her research interests span Clinical Breast Surgical Oncology, including Oncoplastic Surgery, Minimally Invasive and Robotic Breast Surgery, Enhanced Recovery After Surgery (ERAS), and Intraoperative Radiotherapy (IORT). She has published over 70 scientific papers, led the development of Decision Aids in Breast Reconstruction, and is actively involved in multiple clinical trials, including the TARGIT-B trial. Dr. See is also actively engaged in advancing artificial intelligence (AI) in breast cancer diagnosis. She is currently collaborating with Kyungpook National University, Daegu, South Korea, on a clinical trial exploring AI applications for breast cancer diagnostics and treatment planning. A driving force in Dr. See's work is her passion for uniting Southeast Asian and Asian breast surgeons through knowledge sharing and collaboration. She spearheads this effort through the Asian Breast Surgery Forum (ABSF – an ECHO Project), which she leads in collaboration with the University of New Mexico’s Project ECHO®. The forum connects 12 Asian countries, fostering the exchange of expertise and best practices in breast surgery. Dr. See is actively involved in various international surgical organizations, including the International Oncoplastic Breast Surgery (IOPBS) and the International Endoscopic and Robotic Breast Surgery (IERBS) societies, contributing to the global advancement of breast surgical practices. Currently, Dr. See serves as the Deputy Head of the Visibility Unit in the Faculty of Medicine at the University of Malaya. Her leadership and vision continue to impact the field of breast surgery, both regionally and globally, as she remains dedicated to enhancing surgical standards, research, and patient outcomes.